Potential mechanism of Camellia luteoflora against colon adenocarcinoma: An integration of network pharmacology and molecular docking

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-7)

Tables (1-3)

Sum=133

Publishing Process of This Article

Item

Count

Browse

Download

Sum=30

Jun 15, 2025 (publication date) through Jun 16, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jun 15, 2025; 17(6): 105782
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105782

Table 1 The details of Camellia luteoflora ingredients

No.	Ingredient	Molecular formula	Molecular weight (g/mol)
1	Phytol	C20H40O	296.539
2	β-sitosterol	C29H50O	414.707
3	Daucosterol	C35H60O6	576.847
4	Isoquercitrin	C21H20O12	464.376
5	Anethole	C10H12O	148.202
6	1, 2-Di-O-linolenoylglycerol 3-O-β-D-galactopyranoside	C45H74O10	774.528
7	chlorogenic acid	C16H18O9	354.309
8	Cinchonain Ib	C24H20O9	452.410
9	Cinchonain Ia	C24H20O9	452.410
10	Methyl chlorogenate	C17H20O9	368.340
11	Vitrxin-2-O-rhamnoside	C27H30O14	578.519
12	Isovitexin-2-O-rhamnoside	C27H30O14	578.520
13	Roseoside	C19H30O8	386.437

Citation: Dong YD, Wu XM, Liu WQ, Hu YW, Zhang H, Fang WD, Luo Q. Potential mechanism of Camellia luteoflora against colon adenocarcinoma: An integration of network pharmacology and molecular docking. World J Gastrointest Oncol 2025; 17(6): 105782
URL: https://www.wjgnet.com/1948-5204/full/v17/i6/105782.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.105782